Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Öhman, Procuritas, Spiltan and others in connection with the acquisition of 51.1 per cent of the shares in Emric AB
Mandate

Vinge advises Öhman, Procuritas, Spiltan and others in connection with the acquisition of 51.1 per cent of the shares in Emric AB

June 10, 2010

Vinge is advising KB Götaberg 20 (Öhman), Investmentbolaget av 1 maj 2009 AB (Procuritas), Investment AB (Spiltan), Norra Brofästet i Sundsvall AB and F. Månsson Invest AB in connection with the acquisition of 50.1 per cent of the shares in Emric AB from Bisnode AB. Emric is one of Sweden's leading providers of software, expert consultancy and outsourcing services to the banking and financial services sector. The acquisition is based on a call option which was issued in connection with Bisnode's purchase of 50.1 per cent of the shares in Emric in 2007.
 
Vinge's team advising the buyers consists of partner Henrik Wenckert and associates Marie Brommesson and Peter Sundgren.

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025